Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-03-17

Clinical Trial Update: Role of AT1-receptor Blockers in Insulin-induced Vasodilation. [NA]

View source ↗

Summary

A clinical trial update from Maastricht University Medical Center examining whether AT1-receptor blockers influence insulin-induced vasodilation in hypertension…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angiotensin II receptor blockers (ARB) (angiotensin II receptor blocker)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Hypertension, Insulin Resistance | NA | Status: UNKNOWN